CUMBERLAND PHARMACEUTICALS INC (41)

Browse by Contract Category

Contracts

Ninth Amendment to Revolving Credit Loan Agreement, dated as of September 29, 2022, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on November 14, 2022)
Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between Leo B. Pavliv and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)
Lease Agreement, dated November 15, 2021, by and between Cumberland Pharmaceuticals Inc. and 1600 West End Avenue Partners, LLC (Filed With SEC on March 11, 2022)
Amendment No. 1 to the At Market Issuance Sales Agreement, dated December 27, 2021, by and between Cumberland Pharmaceuticals Inc. and B. Riley Securities, Inc. (formerly B. Riley... (Filed With SEC on December 27, 2021)
Exhibit 10.16 dated May 14, 2021 (Filed With SEC on May 14, 2021)
Eighth Amendment to Revolving Credit Loan Agreement, dated as of June 30, 2022, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on August 12, 2022)
Seventh Amendment to Revolving Credit Loan Agreement, dated as of March 31, 2022, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on May 13, 2022)
Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between James L. Herman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)
Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between John M. Hamm and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)
Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between Leo B. Pavliv and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)
Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)
Description of Cumberland Pharmaceutical's Common Stock (Filed With SEC on March 11, 2022)
Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)
Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between Martin E. Cearnal and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)
Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between James L. Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)
Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between (Filed With SEC on March 11, 2022)
Fifth Amendment to the Revolving Credit Note and Sixth Amendment to Revolving Credit Loan Agreement, dated as of December 31, 2021, by and between Cumberland Pharmaceuticals Inc.... (Filed With SEC on March 11, 2022)
Asset Purchase Agreement, dated December 31, 2021, by and among Cumberland Pharmaceuticals Inc. and Kyowa Kirin, Inc (Filed With SEC on January 6, 2022)
Fourth Amendment to Revolving Credit Note and Fifth Amendment to Revolving Credit Loan Agreement, dated as of October 28, 2021, by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on November 12, 2021)
Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between James L. Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 12, 2021)
Employment Agreement dated March (Filed With SEC on March 12, 2021)
Employment Agreement dated March (Filed With SEC on March 12, 2021)
Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on March 12, 2021)
Description of Cumberland Pharmaceutical's Common Stock (Filed With SEC on March 12, 2021)
Employment Agreement dated March (Filed With SEC on March 12, 2021)
Third Amendment to Revolving Credit Note and Fourth Amendment to Revolving Credit Loan Agreement, dated as of October 7, 2020 by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on November 13, 2020)
Payment Protection Program (Filed With SEC on August 14, 2020)
Amendment Number 2 to the Amended and Restated 2007 Director's Incentive Compensation Plan (Filed With SEC on August 14, 2020)
Amendment Number 2 to the Amended and Restated 2007 Long-Term Incentive Compensation Plan (Filed With SEC on August 14, 2020)
Employment Agreement dated March (Filed With SEC on March 20, 2020)
Employment Agreement dated March (Filed With SEC on March 20, 2020)
Employment Agreement dated March (Filed With SEC on March 20, 2020)
Employment Agreement dated March (Filed With SEC on March 20, 2020)
Employment Agreement dated March (Filed With SEC on March 20, 2020)
Second Amendment to Revolving Credit Note and Third Amendment to Revolving Credit Loan Agreement, dated as of May 10, 2019 by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on May 15, 2019)
First Amendment to Revolving Credit Note and Second Amendment to Revolving Credit Loan Agreement, dated as of October 17, 2018, by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on May 15, 2019)
Employment Agreement dated March (Filed With SEC on March 12, 2019)
Employment Agreement dated March (Filed With SEC on March 12, 2019)
Employment Agreement dated March (Filed With SEC on March 12, 2019)
Employment Agreement dated March (Filed With SEC on March 12, 2019)
Employment Agreement dated March (Filed With SEC on March 12, 2019)